Cardiacx

Company Overview

Snapshot

Founded in January 2007, Cardiacx operated with 1–10 employees, developing miniature cardiac resuscitation systems. The company ceased operations in May 2019.

Business overview

Cardiacx specializes in the development, manufacturing, and marketing of miniature cardiac resuscitation systems, including personal defibrillators. The company's core product, the Personal External Defibrillator (PED), is a user-friendly, smartphone-sized portable device designed to significantly shorten response times for sudden cardiac arrest (SCA) events. Cardiacx serves the healthcare and consumer markets, operating within the Health Tech & Life Sciences sector, specifically focusing on medical devices and medical treatment & therapeutics.

Company Intelligence Q&A

What is Cardiacx's primary focus?

Cardiacx develops, manufactures, and markets miniature cardiac resuscitation systems and personal defibrillators, aiming to shorten response times for sudden cardiac arrest.

When was Cardiacx founded?

Cardiacx was founded in January 2007.

What is the status of Cardiacx?

Cardiacx is currently non-active and ceased to operate in May 2019.

What products did Cardiacx offer?

Cardiacx offered the Personal External Defibrillator (PED) in various models, including PED-S for children, PED-M for adults, and PED-L for larger or obese patients.

What markets did Cardiacx target?

Cardiacx targeted global markets, focusing on patients and consumers within the healthcare sector.